Study of Combining Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified July 2012 by Theodor Bilharz Research Institute
Sponsor:
Information provided by (Responsible Party):
Ibrahim Mostafa, Theodor Bilharz Research Institute
ClinicalTrials.gov Identifier:
NCT01653236
First received: July 26, 2012
Last updated: July 30, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)